全文获取类型
收费全文 | 86901篇 |
免费 | 2311篇 |
国内免费 | 46篇 |
出版年
2018年 | 977篇 |
2017年 | 1131篇 |
2016年 | 2917篇 |
2015年 | 6296篇 |
2014年 | 5894篇 |
2013年 | 5673篇 |
2012年 | 4929篇 |
2011年 | 2163篇 |
2010年 | 2200篇 |
2009年 | 2168篇 |
2008年 | 753篇 |
2007年 | 718篇 |
2006年 | 749篇 |
2005年 | 6850篇 |
2004年 | 5501篇 |
2003年 | 3701篇 |
2002年 | 1295篇 |
2001年 | 1129篇 |
2000年 | 344篇 |
1999年 | 1501篇 |
1998年 | 378篇 |
1997年 | 202篇 |
1992年 | 1943篇 |
1991年 | 2027篇 |
1990年 | 2091篇 |
1989年 | 2018篇 |
1988年 | 1978篇 |
1987年 | 1826篇 |
1986年 | 1642篇 |
1985年 | 1674篇 |
1984年 | 1124篇 |
1983年 | 861篇 |
1982年 | 482篇 |
1981年 | 455篇 |
1980年 | 394篇 |
1979年 | 1094篇 |
1978年 | 782篇 |
1977年 | 628篇 |
1976年 | 644篇 |
1975年 | 889篇 |
1974年 | 1006篇 |
1973年 | 1027篇 |
1972年 | 957篇 |
1971年 | 934篇 |
1970年 | 827篇 |
1969年 | 833篇 |
1968年 | 737篇 |
1967年 | 751篇 |
1966年 | 585篇 |
1965年 | 433篇 |
排序方式: 共有10000条查询结果,搜索用时 286 毫秒
171.
Fátima H. Vaz Patrícia M. Machado Rita D. Brand?o Cátia T. Laranjeira Joana S. Eugénio Aires H. Fernandes Saudade P. André 《The journal of histochemistry and cytochemistry》2007,55(11):1105-1113
Only 20-25% of families screened for BRCA1/2 mutations are found positive. Because only a positive result is informative, we studied the role of BRCA1/2 immunohistochemistry as an additional method for patient selection. From 53 high-risk-affected probands, 18 (34%) had available paraffin blocks of their tumors and were selected for this study. Mutation screening was done by conformation-sensitive gel electrophoresis and multiplex ligation-dependent probe amplification. For immunohistochemistry, 21 neoplastic specimens (15 breast carcinomas, 5 ovary neoplasms, and 1 rectal adenocarcinoma) were analyzed with BRCA1 (monoclonal antibody, Ab-1, oncogene) and BRCA2 (polyclonal antibody, Ab-2, oncogene) antibodies. Absence of the BRCA1 protein was confirmed in negative tumors by Western blotting. Seven patients were positive for BRCA1/2 mutations: 5 for BRCA1 and 2 for BRCA2. Four out of five positive patients had tumors negative for BRCA1 immunostaining, and the remaining 13 BRCA1-negative patients had positive BRCA1 immunostaining in all tumor samples. Sensitivity to predict for BRCA1 mutation carriers was 80%, and specificity was 100%, with a positive predictive value of 100% and a negative predictive value of 93%. This correlation was statistically significant (p=0.001). No correlation was observed for BRCA2. If larger studies confirm these results, high-risk patients with BRCA1-negative tumors should be screened first for this gene. 相似文献
172.
173.
Our studies aimed at determining a loss of active heparin from the peritoneal cavity after its intraperitoneal administration (250 JU/l of dialysis fluid) in 16 patients treated because of the end-stage renal failure with intermittent peritoneal dialysis and at comparing heparin influx clearance with that of glucose. It has been shown that heparin used in this dose loses 60-70% of its activity after 20-minute equilibration of dialysis fluid in the peritoneal cavity. Heparin influx clearance is higher than that of glucose but it depends on utilization of heparin in peritoneal cavity rather than on its penetration to the blood circulation. 相似文献
174.
175.
176.
Eric S. J. Harris Shugeng Cao Sean D. Schoville Chengming Dong Wenquan Wang Zaiyou Jian Zhongzhen Zhao David M. Eisenberg Jon Clardy 《PloS one》2012,7(11)
Oridonin is a diterpenoid with anti-cancer activity that occurs in the Chinese medicinal plant Isodon rubescens and some related species. While the bioactivity of oridonin has been well studied, the extent of natural variation in the production of this compound is poorly known. This study characterizes natural variation in oridonin production in order to guide selection of populations of Isodon with highest oridonin yield. Different populations of I. rubescens and related species were collected in China, and their offspring were grown in a greenhouse. Samples were examined for oridonin content, genotyped using 11 microsatellites, and representatives were sequenced for three phylogenetic markers (ITS, rps16, trnL-trnF). Oridonin production was mapped on a molecular phylogeny of the genus Isodon using samples from each population as well as previously published Genbank sequences. Oridonin has been reported in 12 out of 74 species of Isodon examined for diterpenoids, and the phylogeny indicates that oridonin production has arisen at least three times in the genus. Oridonin production was surprisingly consistent between wild-collected parents and greenhouse-grown offspring, despite evidence of gene flow between oridonin-producing and non-producing populations of Isodon. Additionally, microsatellite genetic distance between individuals was significantly correlated with chemical distance in both parents and offspring. Neither heritability nor correlation with genetic distance were significant when the comparison was restricted to only populations of I. rubescens, but this result should be corroborated using additional samples. Based on these results, future screening of Isodon populations for oridonin yield should initially prioritize a broad survey of all species known to produce oridonin, rather than focusing on multiple populations of one species, such as I. rubescens. Of the samples examined here, I. rubescens or I. japonicus from Henan province would provide the best source of oridonin. 相似文献
177.
178.
179.
180.